OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
Timothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101576-101576
Open Access | Times Cited: 23
Timothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101576-101576
Open Access | Times Cited: 23
Showing 23 citing articles:
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 556-567
Open Access | Times Cited: 469
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 556-567
Open Access | Times Cited: 469
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents
Marloes I. Hofstee, Joanna Kaczorowska, Abigail Postema, et al.
Immunity & Ageing (2025) Vol. 22, Iss. 1
Open Access
Marloes I. Hofstee, Joanna Kaczorowska, Abigail Postema, et al.
Immunity & Ageing (2025) Vol. 22, Iss. 1
Open Access
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021
Eline Meyers, Liselore De Rop, Ellen Deschepper, et al.
Vaccine (2025) Vol. 51, pp. 126865-126865
Closed Access
Eline Meyers, Liselore De Rop, Ellen Deschepper, et al.
Vaccine (2025) Vol. 51, pp. 126865-126865
Closed Access
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection
Young Hoon Hwang, Dal‐Hee Min, Wan Beom Park
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Young Hoon Hwang, Dal‐Hee Min, Wan Beom Park
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
Théophile Cocherie, Karen Zafilaza, Valentin Leducq, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 22
Théophile Cocherie, Karen Zafilaza, Valentin Leducq, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 22
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021
Tom Woudenberg, Laurie Pinaud, Laura García, et al.
Eurosurveillance (2023) Vol. 28, Iss. 25
Open Access | Times Cited: 11
Tom Woudenberg, Laurie Pinaud, Laura García, et al.
Eurosurveillance (2023) Vol. 28, Iss. 25
Open Access | Times Cited: 11
A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 11
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 11
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
Quentin Clairon, Mélanie Prague, Delphine Planas, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011282-e1011282
Open Access | Times Cited: 9
Quentin Clairon, Mélanie Prague, Delphine Planas, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011282-e1011282
Open Access | Times Cited: 9
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
Simon Woelfel, Joel Dütschler, Marius König, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 678-691
Closed Access | Times Cited: 6
Simon Woelfel, Joel Dütschler, Marius König, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 678-691
Closed Access | Times Cited: 6
Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine
Alexander Rouvinski, Ahuva Friedman, Saveliy Kirillov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Alexander Rouvinski, Ahuva Friedman, Saveliy Kirillov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
Yi-Chan Lin, David H. Evans, Ninette F. Robbins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 7
Yi-Chan Lin, David H. Evans, Ninette F. Robbins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 7
Modelling the association between neutralizing antibody levels and SARS-CoV-2 viral dynamics : implications to define correlates of protection against infection
Guillaume Lingas, Delphine Planas, Hélène Péré, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Guillaume Lingas, Delphine Planas, Hélène Péré, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Neutralizing Antibody Levels as a Correlate of Protection Against SARS‐CoV ‐2 Infection: A Modeling Analysis
Guillaume Lingas, Delphine Planas, Hélène Péré, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 1, pp. 86-94
Open Access | Times Cited: 3
Guillaume Lingas, Delphine Planas, Hélène Péré, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 1, pp. 86-94
Open Access | Times Cited: 3
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Safety, Immunogenicity, and Antibody Persistence of COVID-19 Boosters in BBIP-CorV Immunized Individuals with Comorbidities
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
(2023)
Open Access | Times Cited: 2
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
(2023)
Open Access | Times Cited: 2
A Mechanical Assay for the Quantification of Anti-RBD IgG Levels in Finger-Prick Whole Blood
Yu Zhou, Xiaodan Zhao, Yanqige Jiang, et al.
ACS Sensors (2023) Vol. 8, Iss. 8, pp. 2986-2995
Open Access | Times Cited: 2
Yu Zhou, Xiaodan Zhao, Yanqige Jiang, et al.
ACS Sensors (2023) Vol. 8, Iss. 8, pp. 2986-2995
Open Access | Times Cited: 2
Age-Related Differences in Neutralizing Antibody Responses against SARS-CoV-2 Delta and Omicron Variants in 151 SARS-CoV-2-Naïve Metropolitan Residents Boosted with BNT162b2
Beomki Lee, Go Eun Bae, In Hwa Jeong, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 4, pp. 741-751
Closed Access
Beomki Lee, Go Eun Bae, In Hwa Jeong, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 4, pp. 741-751
Closed Access
Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort Study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Research Square (Research Square) (2024)
Closed Access
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Research Square (Research Square) (2024)
Closed Access
Health characteristics associated with persistence of SARS-CoV-2 antibody responses after repeated vaccinations in older persons over time: the Doetinchem cohort study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study
Xin Zhang, Li Li, Yongmei Liu, et al.
Viral Immunology (2024) Vol. 37, Iss. 10, pp. 480-488
Closed Access
Xin Zhang, Li Li, Yongmei Liu, et al.
Viral Immunology (2024) Vol. 37, Iss. 10, pp. 480-488
Closed Access
Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294262-e0294262
Open Access | Times Cited: 1
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294262-e0294262
Open Access | Times Cited: 1
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021–2022
Lisa Perrig, Irène A. Abela, Nicolas Banholzer, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 12, pp. 3502-3502
Open Access
Lisa Perrig, Irène A. Abela, Nicolas Banholzer, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 12, pp. 3502-3502
Open Access
